Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN87,587,54-0,79
Msft0,56
Nokia4,1014,232-4,06
IBM-0,38
Mercedes-Benz Group AG52,6752,681,49
PFE-2,92
16.07.2025 1:38:59
Indexy online
AD Index online
select
AD Index online
 

  • 15.07.2025
Biofarm Bucurest (ROBIO.BX, Bucharest)
Závěr k 15.7.2025 Změna (%) Změna (RON) Objem obchodů (RON)
0,886 0,91 0,01 35 369
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 16.07.2025
Popis společnosti

Business Summary: Biofarm SA is a Romania-based company engaged in the pharmaceutical sector. The Company focuses on the production and marketing of pharmaceutical preparations. The Company is active in the manufacture and wholesale of over the counter drugs, prescription medications and dietary supplements. The Company’s product portfolio includes pharmaceutical preparations for digestive system, musculoskeletal system, immune stimulation, respiratory system, cold and flu symptoms and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants and cosmetics, among others. Additionally, the Company offers services, such as consultancy on Romanian pharmaceutical market, manufacturing of non-sterile products, the investment in research, promotion and packaging. The main shareholder of the Company is Societatea de Investitii Financiare Muntenia SA.
Financial Summary: BRIEF: For the nine months ended 30 September 2024, Biofarm SA revenues increased 1% to RON231.1M. Net income increased 5% to RON73.3M. Revenues reflect Gross Income from Sales increase of 7% to RON359.3M. Net income benefited from Advertising & Promotion decrease of 15% to RON34.2M (expense), Other Other Operating Expense decrease of 6% to RON12M (expense), Other Services from Third Parties decrease of 1% to RON7.6M (expense).



  • Poslední aktualizace: 16.07.2025
Management společnosti
Data nejsou k dispozici